Isabel Blancas

10PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthPharmacogenomicsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 14, 2026
The Early Safety Signal of Sacituzumab Govitecan-Related Toxicity and the UGT1A1*28 Genotype in Metastatic Breast Cancer: A Real-World Preliminary Report.

María Martínez-Pérez, María Teresa Nieto-Sánchez, Xando Díaz-Villamarín

|Mar 12, 2026
Clinical experience and satisfaction in patients with advanced breast cancer participating in the abemaciclib patient support program in Spain: a prospective observational study.

Isabel Blancas, Miriam González de la Peña, María Fernández Abad

|Jun 25, 2025
Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine.

Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez

|Jun 04, 2025
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial.

María Gion, Isabel Blancas, Patricia Cortez-Castedo

|Apr 11, 2025
Influence of CYP2D6 polymorphisms on tamoxifen side effects in patients with breast cancer.

Isabel Blancas, Marina Linares-Rodríguez, Carlos José Rodríguez-González

|Aug 08, 2024
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain.

Isabel Blancas, Jessica Grosjean, Rebecca Pedersini

Pageof 2

Frequent Collaborators

2 joint publications

Jose Angel Garcia-Saenz

2 joint publications

Isabel Echavarria

2 joint publications

Carmen Hinojo

2 joint publications

Fernando Moreno